Cargando…

The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer’s Disease Pathogenesis

Alzheimer’s disease (AD), the most common form of dementia in elderly individuals, is marked by progressive neuron loss. Despite more than 100 years of research on AD, there is still no treatment to cure or prevent the disease. High levels of amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jasiecki, Jacek, Targońska, Monika, Wasąg, Bartosz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922581/
https://www.ncbi.nlm.nih.gov/pubmed/33670778
http://dx.doi.org/10.3390/ijms22042033
_version_ 1783658723948888064
author Jasiecki, Jacek
Targońska, Monika
Wasąg, Bartosz
author_facet Jasiecki, Jacek
Targońska, Monika
Wasąg, Bartosz
author_sort Jasiecki, Jacek
collection PubMed
description Alzheimer’s disease (AD), the most common form of dementia in elderly individuals, is marked by progressive neuron loss. Despite more than 100 years of research on AD, there is still no treatment to cure or prevent the disease. High levels of amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain are neuropathological hallmarks of AD. However, based on postmortem analyses, up to 44% of individuals have been shown to have high Aβ deposits with no clinical signs, due to having a “cognitive reserve”. The biochemical mechanism explaining the prevention of cognitive impairment in the presence of Aβ plaques is still unknown. It seems that in addition to protein aggregation, neuroinflammatory changes associated with aging are present in AD brains that are correlated with a higher level of brain iron and oxidative stress. It has been shown that iron accumulates around amyloid plaques in AD mouse models and postmortem brain tissues of AD patients. Iron is required for essential brain functions, including oxidative metabolism, myelination, and neurotransmitter synthesis. However, an imbalance in brain iron homeostasis caused by aging underlies many neurodegenerative diseases. It has been proposed that high iron levels trigger an avalanche of events that push the progress of the disease, accelerating cognitive decline. Patients with increased amyloid plaques and iron are highly likely to develop dementia. Our observations indicate that the butyrylcholinesterase (BChE) level seems to be iron-dependent, and reports show that BChE produced by reactive astrocytes can make cognitive functions worse by accelerating the decay of acetylcholine in aging brains. Why, even when there is a genetic risk, do symptoms of the disease appear after many years? Here, we discuss the relationship between genetic factors, age-dependent iron tissue accumulation, and inflammation, focusing on AD.
format Online
Article
Text
id pubmed-7922581
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79225812021-03-03 The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer’s Disease Pathogenesis Jasiecki, Jacek Targońska, Monika Wasąg, Bartosz Int J Mol Sci Review Alzheimer’s disease (AD), the most common form of dementia in elderly individuals, is marked by progressive neuron loss. Despite more than 100 years of research on AD, there is still no treatment to cure or prevent the disease. High levels of amyloid-β (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain are neuropathological hallmarks of AD. However, based on postmortem analyses, up to 44% of individuals have been shown to have high Aβ deposits with no clinical signs, due to having a “cognitive reserve”. The biochemical mechanism explaining the prevention of cognitive impairment in the presence of Aβ plaques is still unknown. It seems that in addition to protein aggregation, neuroinflammatory changes associated with aging are present in AD brains that are correlated with a higher level of brain iron and oxidative stress. It has been shown that iron accumulates around amyloid plaques in AD mouse models and postmortem brain tissues of AD patients. Iron is required for essential brain functions, including oxidative metabolism, myelination, and neurotransmitter synthesis. However, an imbalance in brain iron homeostasis caused by aging underlies many neurodegenerative diseases. It has been proposed that high iron levels trigger an avalanche of events that push the progress of the disease, accelerating cognitive decline. Patients with increased amyloid plaques and iron are highly likely to develop dementia. Our observations indicate that the butyrylcholinesterase (BChE) level seems to be iron-dependent, and reports show that BChE produced by reactive astrocytes can make cognitive functions worse by accelerating the decay of acetylcholine in aging brains. Why, even when there is a genetic risk, do symptoms of the disease appear after many years? Here, we discuss the relationship between genetic factors, age-dependent iron tissue accumulation, and inflammation, focusing on AD. MDPI 2021-02-18 /pmc/articles/PMC7922581/ /pubmed/33670778 http://dx.doi.org/10.3390/ijms22042033 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Jasiecki, Jacek
Targońska, Monika
Wasąg, Bartosz
The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer’s Disease Pathogenesis
title The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer’s Disease Pathogenesis
title_full The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer’s Disease Pathogenesis
title_fullStr The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer’s Disease Pathogenesis
title_full_unstemmed The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer’s Disease Pathogenesis
title_short The Role of Butyrylcholinesterase and Iron in the Regulation of Cholinergic Network and Cognitive Dysfunction in Alzheimer’s Disease Pathogenesis
title_sort role of butyrylcholinesterase and iron in the regulation of cholinergic network and cognitive dysfunction in alzheimer’s disease pathogenesis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922581/
https://www.ncbi.nlm.nih.gov/pubmed/33670778
http://dx.doi.org/10.3390/ijms22042033
work_keys_str_mv AT jasieckijacek theroleofbutyrylcholinesteraseandironintheregulationofcholinergicnetworkandcognitivedysfunctioninalzheimersdiseasepathogenesis
AT targonskamonika theroleofbutyrylcholinesteraseandironintheregulationofcholinergicnetworkandcognitivedysfunctioninalzheimersdiseasepathogenesis
AT wasagbartosz theroleofbutyrylcholinesteraseandironintheregulationofcholinergicnetworkandcognitivedysfunctioninalzheimersdiseasepathogenesis
AT jasieckijacek roleofbutyrylcholinesteraseandironintheregulationofcholinergicnetworkandcognitivedysfunctioninalzheimersdiseasepathogenesis
AT targonskamonika roleofbutyrylcholinesteraseandironintheregulationofcholinergicnetworkandcognitivedysfunctioninalzheimersdiseasepathogenesis
AT wasagbartosz roleofbutyrylcholinesteraseandironintheregulationofcholinergicnetworkandcognitivedysfunctioninalzheimersdiseasepathogenesis